Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Clinical Immunology · CARD9 Deficiency

Getting an Accurate Diagnosis: Labs and Genetics

At a Glance

CARD9 deficiency can cause severe or recurrent fungal infections even when white blood cell counts, oxidative burst testing, and antibody levels are normal. Diagnosis usually combines the infection history with testing for pathogenic or likely pathogenic variants in both CARD9 gene copies.

If you have experienced severe, recurring, or unusual fungal infections, your doctors may have already run several blood tests. A frustrating reality for many patients with CARD9 deficiency is that these standard tests often come back completely normal [1][2]. This can lead to delays in diagnosis because the “standard” tools for checking the immune system aren’t designed to find this specific bridge-building error.

Why Routine Labs Often Miss CARD9

Most basic immune tests check the quantity and basic hardware of your immune system. In CARD9 deficiency, your body usually has the right number of cells and those cells have functioning “weapons,” but they lack the “orders” to use them against fungi [1].

  • Normal White Blood Cell (WBC) & Neutrophil Counts: Your body typically produces a normal number of white blood cells. Unlike other immunodeficiencies where cells are missing, CARD9 patients have plenty of neutrophils (fungus-killing cells) circulating in their blood [1][3].
  • Normal Oxidative Burst: This test (often called a DHR or NBT test) checks if your neutrophils can produce “reactive oxygen species” (the chemical “bleach” needed to kill germs). In CARD9 deficiency, this machinery is usually perfectly intact, which is why doctors may mistakenly rule out an immune defect [1][4].
  • Normal Antibodies: Your immunoglobulins (IgG, IgA, IgM) are the proteins that recognize viruses and bacteria. These are typically normal in CARD9 patients, meaning you can still fight off most common illnesses [1].

Definitive Diagnosis: Genetic Testing

A definitive diagnosis generally requires a compatible clinical picture combined with genetic testing [1]. Doctors look for biallelic variants, which means there is a mutation in both copies of your CARD9 gene (one from each parent) [5][6]. To establish the diagnosis, these variants must be interpreted as pathogenic or likely pathogenic; two variants of uncertain significance (VUS) do not establish the diagnosis on their own.

This testing is usually done via:

  1. Targeted Gene Panels: A test that looks at a specific group of genes known to cause immune problems.
  2. Whole Exome or Genome Sequencing: A broader search through your entire genetic code to find the specific “typo” in the CARD9 gene [7]. Note that some sequencing approaches can miss copy-number, structural, or difficult intronic variants.

Specialized Functional Testing

If genetic results are unclear, or if doctors want to see how the mutation affects your health, they may use functional assays to help interpret the genetics. These are specialized, lab-dependent tests usually performed in reference or research settings.

  • Fungal-Stimulated Cytokine Production: Scientists mix your white blood cells with fungi like Candida. In a healthy person, the cells release “alarm chemicals” (cytokines like TNF-alpha or IL-6). In CARD9 deficiency, the cells remain mostly silent [5][8].
  • Neutrophil Killing Assays: This test checks if your neutrophils can actually kill a fungus when they are put right next to it. Some CARD9 patients show a reduced ability to kill certain fungi in these “petri dish” tests [9].

Distinguishing CARD9 from Similar Conditions

It is important to differentiate CARD9 deficiency from other disorders in the CBM complex (CARD11, BCL10, and MALT1) [1].

  • Broad vs. Specific: While CARD9 deficiency is almost exclusively a “fungal-only” problem, defects in CARD11, BCL10, or MALT1 usually cause a much broader “Combined Immunodeficiency” [10]. These patients often struggle with viruses, bacteria, and poor antibody production, which are not typical for CARD9 deficiency [11][12].

Testing for the Family

Because this is an inherited condition, genetic counseling and targeted cascade testing are strongly recommended for close relatives, especially siblings [1]. Even if a sibling feels perfectly healthy today, they could have the same genetic profile and be at risk for a sudden, severe infection later in life [5]. Knowing the diagnosis early allows for proactive monitoring and faster treatment if symptoms ever appear [5].

Common questions in this guide

Why can routine immune tests look normal in someone with CARD9 deficiency?
CARD9 deficiency usually affects immune signaling rather than the number of white blood cells or the basic killing machinery measured by oxidative burst tests. White blood cell counts, neutrophil counts, oxidative burst results, and immunoglobulin levels may all be normal despite serious fungal infections.
What genetic findings support a diagnosis of CARD9 deficiency?
A diagnosis generally combines a compatible history of severe, recurrent, or unusual fungal infections with pathogenic or likely pathogenic variants in both copies of the CARD9 gene. Two variants of uncertain significance do not establish the diagnosis by themselves.
Which genetic tests can find CARD9 deficiency?
A targeted immune-gene panel, whole-exome sequencing, or whole-genome sequencing may identify CARD9 variants. Some sequencing methods can miss missing or extra gene segments, larger structural changes, or difficult intronic variants, so the test method and its limitations matter.
Can functional tests help when CARD9 genetic results are unclear?
Yes. Specialized tests can measure how blood cells release signaling proteins after exposure to fungi or how well neutrophils kill fungi. These assays are usually performed in reference or research laboratories and may help interpret uncertain genetic findings.
Should siblings and other relatives be tested for CARD9 deficiency?
Because CARD9 deficiency is inherited, genetic counseling and targeted testing are recommended for close relatives, especially siblings. Testing can identify someone at risk even before symptoms occur and may support earlier monitoring and treatment of a serious fungal infection.
How is CARD9 deficiency distinguished from chronic granulomatous disease?
CARD9 deficiency typically has a normal oxidative burst test, while chronic granulomatous disease commonly causes an abnormal result on this test. Doctors also consider the types of infections, the broader immune test results, and genetic findings when distinguishing these conditions.

Get notified when new evidence is published on Predisposition to invasive fungal disease due to CARD9 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Inherited CARD9 Deficiency: Invasive Disease Caused by Ascomycete Fungi in Previously Healthy Children and Adults.

    Corvilain E, Casanova JL, Puel A

    Journal of clinical immunology 2018; (38(6)):656-693 doi:10.1007/s10875-018-0539-2.

    PMID: 30136218
  2. 2

    Extrapulmonary Aspergillus infection in patients with CARD9 deficiency.

    Rieber N, Gazendam RP, Freeman AF, et al.

    JCI insight 2016; (1(17)):e89890.

    PMID: 27777981
  3. 3

    CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System.

    Drummond RA, Collar AL, Swamydas M, et al.

    PLoS pathogens 2015; (11(12)):e1005293 doi:10.1371/journal.ppat.1005293.

    PMID: 26679537
  4. 4

    CARD9 deficiencies linked to impaired neutrophil functions against Phialophora verrucosa.

    Liang P, Wang X, Wang R, et al.

    Mycopathologia 2015; (179(5-6)):347-57 doi:10.1007/s11046-015-9877-2.

    PMID: 25790941
  5. 5

    Inherited CARD9 Deficiency in a Child with Invasive Disease Due to Exophiala dermatitidis and Two Older but Asymptomatic Siblings.

    Imanaka Y, Taniguchi M, Doi T, et al.

    Journal of clinical immunology 2021; (41(5)):975-986 doi:10.1007/s10875-021-00988-7.

    PMID: 33558980
  6. 6

    Mechanistic Insights into the Role of C-Type Lectin Receptor/CARD9 Signaling in Human Antifungal Immunity.

    Drummond RA, Lionakis MS

    Frontiers in cellular and infection microbiology 2016; (6()):39 doi:10.3389/fcimb.2016.00039.

    PMID: 27092298
  7. 7

    A novel inherited CARD9 deficiency in an otherwise healthy woman with CNS candidiasis.

    Zhou LH, Qiu WJ, Que CX, et al.

    Clinical immunology (Orlando, Fla.) 2024; (265()):110293 doi:10.1016/j.clim.2024.110293.

    PMID: 38936523
  8. 8

    Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both.

    Lanternier F, Mahdaviani SA, Barbati E, et al.

    The Journal of allergy and clinical immunology 2015; (135(6)):1558-68.e2.

    PMID: 25702837
  9. 9

    Chronic Candida albicans Meningitis in a 4-Year-Old Girl with a Homozygous Mutation in the CARD9 Gene (Q295X).

    Herbst M, Gazendam R, Reimnitz D, et al.

    The Pediatric infectious disease journal 2015; (34(9)):999-1002 doi:10.1097/INF.0000000000000736.

    PMID: 25933095
  10. 10

    Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.

    Pérez de Diego R, Sánchez-Ramón S, López-Collazo E, et al.

    The Journal of allergy and clinical immunology 2015; (136(5)):1139-49.

    PMID: 26277595
  11. 11

    A novel case of autosomal recessive CARD11 loss-of-function underlying impaired antiviral immunity and a review of literature.

    Anderson H, Verryt C, Keating P, et al.

    Clinical & translational immunology 2026; (15()):e70066 doi:10.1002/cti2.70066.

    PMID: 42110384
  12. 12

    Loss of MALT1 Function in a Patient With Combined Immunodeficiency: a Novel Pathogenic Variant and Immunological Insights.

    Tian Z, Chen R, Jia Y, et al.

    Journal of clinical immunology 2025; (45(1)):119.

    PMID: 40748513

This page is for informational purposes only and does not constitute medical advice. An immunologist or genetics specialist should interpret your CARD9 testing and guide testing for you and your family.